Header Image

Medical treatment I

Guselkumab in the treatment of patients with hidradenitis suppurativa:
a case series (abstract ID 39)

Certolizumab pegol or brodalumab as reliable therapeutic option for
coexisting hidradenitis suppurativa with psoriasis (abstract ID 40)

Successful treatment of pyoderma gangrenosum, acne, hidradenitis
suppurativa and spondyloarthritis (PASS) syndrome with infliximab and
methotrexate (abstract ID 50)

PsAPSASH syndrome: a new phenotype of a hidradenitis suppurativarelated autoinflammatory syndrome treated with the IL-17A inhibitor secukinumab (abstract ID 51)

Clinical evaluation of adalimumab biosimilar Imraldi in hidradenitis
suppurativa (abstract ID 57)

Adalimumab dose deintensification in hidradenitis suppurativa
(abstract ID 64)

The role of doxycycline and clindamycin in hidradenitis suppurativa: a
prospective cohort study (abstract ID 67)

Dapsone therapy for hidradenitis suppurativa (abstract ID 68)

Experience of ustekinumab in the management of hidradenitis
suppurativa (abstract ID 69)

External evaluation of population pharmacokinetic model of
adalimumab in patients with hidradenitis suppurativa (abstract ID 76)

Adalimumab dose intensification in recalcitrant hidradenitis
suppurativa (abstract ID 85)